Ignite Creation Date:
2024-05-06 @ 2:06 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04210843
Status:
TERMINATED
Last Update Posted:
2024-06-20
First Post:
2019-12-17
Brief Title:
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab
Sponsor:
Organization:
Novartis